HealthQuill
Scientists are embarking on a journey to build a plant that yields nutritious food, survives heatwaves and leaves that grow useful materials.
Climate Drugs Health

UK scientists to build world’s first artificial plant chromosome, chloroplasts

HQ Team June 12, 2025: Scientists are embarking on a journey to build a plant that yields nutritious food, survives heatwaves and leaves.

Read More
Appendiceal cancer tripled in Americans born between 1976 and 1984 and quadrupled for those born between 1981 and 1989, according to a study.
Drugs Health Research

Sharp rise in appendix cancer among Gen X,  millennials in US

HQ Team June 12, 2025: Appendiceal cancer tripled in Americans born between 1976 and 1984 and quadrupled for those born between 1981 and 1989,.

Read More
A machine developed by US-based HistoSonics Inc. to treat patients with primary and secondary liver tumours and other hard-to-reach tumours will be installed at the UK’s Cambridge University Hospitals later this year.
Drugs Health Pharma

UK patients to be first to get non-invasive liver cancer treatment in Europe

HQ Team June 12, 2025: A machine developed by US-based HistoSonics Inc. to treat patients with primary and secondary liver tumours and other.

Read More
Novavax Inc.’s investigational vaccine that protects against both Covid-19 and seasonal flu in a single shot has generated a “strong immune response” during end-stage trials, the company stated.
Drugs Health Pharma

Novavax’s Covid-19-influenza vaccine trial yields ‘strong’ immune response

HQ Team June 12, 2025: Novavax Inc.’s investigational vaccine that protects against both Covid-19 and seasonal flu in a single shot has generated.

Read More
The US Food and Drug Administration has approved Nuvation Bio Inc.’s medicine for adults who have a rare type of lung cancer caused by a specific genetic change.
Drugs Health Pharma

US drug regulator greenlights Nuvation’s rare lung cancer medicine

HQ Team June 11, 2025: The US Food and Drug Administration has approved Nuvation Bio Inc.’s medicine for adults who have a rare.

Read More
Denmark’s Novo Nordisk A/S and US-based Deep Apple Therapeutics Inc. signed an $812 million agreement to develop an oral small molecule targeting cardiometabolic diseases, such as obesity.
Climate Health Research

Novo Nordisk in $812m pact with Deep Apple for oral small molecule

HQ Team June 11, 2025: Denmark’s Novo Nordisk A/S and US-based Deep Apple Therapeutics Inc. signed an $812 million agreement to develop an.

Read More
Ocean acidification, a process by which the world’s oceans absorb excess carbon dioxide from the atmosphere, becoming more acidic, crossed a “planetary boundary” or safety limit five years ago, a study finds.
Climate Health Research

Ocean acidification: ‘A ticking time bomb’ for marine systems, study finds

HQ Team June 11, 2025: Ocean acidification, a process by which the world’s oceans absorb excess carbon dioxide from the atmosphere, becoming more.

Read More
The US drug regulator has put on hold two trials of Gilead Sciences Inc., testing a combination of two of its investigational HIV treatments, after some patients developed lower immune cell counts.
Drugs Health Pharma

Gilead Sciences’ HIV experimental trials put on hold by US drug regulator

HQ Team June 11, 2025: The US drug regulator has put on hold two trials of Gilead Sciences Inc., testing a combination of.

Read More
US President Donald Trump’s administration has sacked all 17 vaccine experts from an advisory panel to the Centers for Disease Control (CDC) and Prevention to “restore public trust.”
Drugs Health Pharma

US health secretary Kennedy fires all 17 members of vaccine advisory panel

HQ Team June 10, 2025: US President Donald Trump’s administration has sacked all 17 vaccine experts from an advisory panel to the Centers.

Read More
Merck & Co.’s two oral cholesterol pill trials — one mid-stage and the other end-stage — showed “positive top-line results” on the efficacy and safety of the treatment in adults, according to the company.
Drugs Health Pharma

Merck’s oral pill for bad cholesterol shows ‘positive’ data during trials

HQ Team June 10, 2025: Merck & Co.’s two oral cholesterol pill trials — one mid-stage and the other end-stage — showed “positive.

Read More